Article Text

Download PDFPDF
Intra-articular corticosteroid injections with the reciprocating procedure device reduced procedural pain and duration more than the conventional syringe

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

 Q In patients receiving intra-articular corticosteroid injections (IACSIs), is the reciprocating procedure device (RPD) more effective than the conventional syringe?

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Rheumatology ★★★★★★☆IM/Ambulatory care ★★★★☆☆☆


Embedded ImageDesign:

randomised controlled trial (RCT).

Embedded ImageAllocation:


Embedded ImageBlinding:

blinded {data analysts and data safety and monitoring committee}.*

Embedded ImageFollow up period:

2 weeks.

Embedded ImageSetting:

{rheumatology clinic in the University of New Mexico Health Sciences Centre, Albuquerque, New Mexico, USA}†.

Embedded ImagePatients:

104 patients (mean age 52 y, 82% women) who had a swollen, painful large (hip, knee) or intermediate sized joint (shoulder, ankle, wrist); rheumatoid arthritis, idiopathic monarthritis, osteoarthritis, reactive arthritis, systemic lupus erythematosus, or acute gout; and required IACSIs for usual medical care. …

View Full Text


  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr W L Sibbitt, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. wsibbitt{at}

  • Sources of funding: no external funding.